Una revisión, disponible en un servidor de preimpresión, de 52 estudios sobre la efectividad de las vacunas disponibles contra la COVID-19 luego de aplicar los refuerzos encontró que:[1] Incluso con refuerzo todas las vacunas disponibles contra la COVID-19 tienen una menor efectividad (52,5%) para evitar infección sintomática por ómicron que la que […]
If you have heart disease, or have survived a heart attack or stroke, you know it can be challenging – even during normal times. COVID-19 has added another layer of worry, leaving many people with heart disease and other conditions on even higher alert than usual to stay healthy. Experts […]
Worldwide childhood vaccinations continued to decline in 2021, fueled by a multitude of factors from COVID-19 to challenging immunization settings, according to a statement by the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF). The percentage of children who received 3 doses of the vaccine against diphtheria-tetanus-pertussis (DTP)—a marker […]
This site provides an integrated, county view of key data for monitoring the COVID-19 pandemic in the United States. It allows for the exploration of standardized data across the country.§ The footnotes describe each data source and the methods used for calculating the metrics. For the most complete and up-to-date data […]
Tixagevimab-cilgavimab is a combination medication to help prevent COVID-19 infection. Tixagevimab-cilgavimab (Evusheld) consists of 2 long-acting monoclonal antibodies that bind to the spike protein of the virus that causes COVID-19 to prevent it from infecting human cells. When Can Tixagevimab-Cilgavimab Be Given? Tixagevimab-cilgavimab is not a treatment for COVID-19 and […]
El nuevo virus forma parte de los Sarbecovirus, que es un subgénero del Betacoronavirus a los que pertenecen los Coronavirus. El patógeno bautizado como Khosta-2 tiene la capacidad para entrar en las células humanas y podría ser resistente a las vacunas actuales. La investigación científica sobre el hallazgo fue publicada […]
To say that Krystal Lashley went to great lengths to get the Novavax COVID-19 vaccine (NVX-CoV2373) would be a gross understatement. In April, Lashley traveled roughly 3700 miles from her home in Metuchen, New Jersey, to a pharmacy in Paris, France, for her first dose. She then flew to the […]
Most people who get infected with non-polio enteroviruses do not get sick, or they only have mild illness, like the common cold. Symptoms of mild illness can include fever, runny nose, sneezing, cough, skin rash, mouth blisters, and body and muscle aches. Three better-known non-polio enteroviruses are enterovirus D68 (EV-D68), […]
Lo que necesita saber Los CDC recomiendan que todas las personas mantengan al día su vacunación contra el COVID-19, incluidas todas las dosis del esquema principal y las dosis de refuerzo correspondientes a su grupo de edad: Las personas de 6 meses a 4 años deben recibir todas las dosis del esquema […]
JYNNEOS vaccine is approved for prevention of smallpox and monkeypox. It is the primary vaccine being used in the U.S. during this outbreak. The JYNNEOS vaccine is given as a two-dose series. The two doses should be given 28 days apart. CDC recommends getting both doses of JYNNEOS vaccine. The […]
